SNT 2.86% 3.4¢ syntara limited

"Who would invest in Biotechs now with so many failures in the...

  1. 11,703 Posts.
    lightbulb Created with Sketch. 1690
    "Who would invest in Biotechs now with so many failures in the sector."

    That's like saying who would invest in mining, following a few drilling failures.

    The thing is PXS has always been very low grade stuff, so this is of no surprise to me at all. A large resource, but very low grade.

    As for the sub group, that's a waste of time too imho. There will always be some subgroups that show significance. If they did deep enough they may find a good one with complete response (like those who own a Toyota Corolla).

    A sad day for PXS, which once had a massive market cap - but of no surprise imho.

    As for the cash pile, well they will just burn it up. The asthma test is non commercial too, and probably always will be.

    cheers, and best wishes to holders. Whilst I always believed PXS was overvalued I take no pleasure from seeing shareholders get hit like this. Especially after that famous trade by the last ceo.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.4¢
Change
-0.001(2.86%)
Mkt cap ! $43.87M
Open High Low Value Volume
3.5¢ 3.5¢ 3.4¢ $14.00K 402.4K

Buyers (Bids)

No. Vol. Price($)
3 440288 3.4¢
 

Sellers (Offers)

Price($) Vol. No.
3.6¢ 374403 3
View Market Depth
Last trade - 15.50pm 30/08/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.